Burst Diagnostics, a Fort Collins, CO-based rapid diagnostics company, raised an undisclosed amount in Seed funding.
The round was led by Innosphere Ventures Fund, with participation from Zymo Research.
The company intends to use the funds to expedite the translation of its platform from a working prototype to a commercial system capable of disrupting the >$45B point-of-care diagnostics industry.
Led by Dr. Charles Henry, Founder and CEO, and Dr. Rose Nash, Chief Operating Officer and Scientist Burst Diagnostics is a diagnostics company which has developed a rapid antigen diagnostics platform for at-home and point-of-care diagnostics testing. The platform is based on a novel microfluidic cartridge capable of miniaturizing and integrating all of the classic steps performed in the clinical laboratory setting (including washing and signal amplification) in a power-free hand-held device.